Status:
COMPLETED
Protein Kinase N1 Level in Patients Undergoing Cardiac Surgery
Lead Sponsor:
Zhongnan Hospital
Conditions:
Acute Kidney Injury
Extracorporeal Circulation; Complications
Eligibility:
All Genders
18+ years
Brief Summary
Acute kidney injury (AKI) is one of the most frequent major complications in patients undergoing cardiac surgery. CSA-AKI is independently related to increased perioperative mortality, increased hospi...
Detailed Description
Acute kidney injury (AKI) is one of the most frequent major complications in patients undergoing cardiac surgery. The incidence of cardiac surgery-associated AKI (CSA-AKI) varies from 5% to 42% and is...
Eligibility Criteria
Inclusion
- Patients (≥18 years old) underwent on-pump cardiac surgery
- admitted to ICU immediately after surgery
Exclusion
- Patients younger than 18 years
- with prior AKI
- end-stage kidney disease
- need for chronic hemodialysis
- pregnant patients
- unable to give written consent for participation
Key Trial Info
Start Date :
July 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 14 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05386940
Start Date
July 22 2019
End Date
March 14 2021
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China, 430000